Literature DB >> 17949665

[Carcinoma of the anterior commissure].

Jesús Herranz1, Javier Gavilán, Juan C Vázquez-Barros.   

Abstract

Treatment of glottic carcinoma with anterior commissure involvement is under debate. Treatment spectrum includes surgery, open or endoscopic, and radiotherapy. Since similar results are reported in the literature, preferences depend on experience and skill of the person responsible for treatment. Our objective is the analysis of scientific data published in Medline, CancerLit, Cochrane Register, and EMBASE, between 1996 and 2007. Twenty-five articles matched our selection criteria. None was a controlled randomized, double-blind trial, clinical guidelines, or a meta-analysis. Eleven were historical, 7 clinical trials, 6 review articles, and 1 was a Cochrane review. There is no scientific data to support recommendations for the most effective treatment in patients with squamous cell carcinoma of the anterior commissure. The available evidence is level 5, with a D recommendation grade.

Entities:  

Mesh:

Year:  2007        PMID: 17949665

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  3 in total

Review 1.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

2.  Functional organ preservation in laryngeal and hypopharyngeal cancer.

Authors:  Petra Ambrosch; Asita Fazel
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

3.  Middle frontal horizontal partial laryngectomy (MFHPL): a treatment for stage T1b squamous cell carcinoma of the glottic larynx involving anterior vocal commissure.

Authors:  Wen-bin Lei; Ai-yun Jiang; Li-ping Chai; Xiao-lin Zhu; Zhang-feng Wang; Yi-hui Wen; Zhen-zhong Su; Wei-ping Wen
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.